logo-loader
viewPressure BioSciences, Inc.

Full interview: Pressure BioSciences PCT instrument deemed ‘essential’ by OB-GYN chair at gynecologic cancer meeting in in Brazil

Pressure BioSciences Inc (OTCMKTS:PBIO) CEO Ric Schumacher tells Proactive the Massachusetts-based company’s patented pressure cycling technology (PCT) was featured in a presentation at the Annual Meeting of the Gynecologic Cancer Society in Brazil. 

Schumacher explains the company’s PCT platform was used as part of a new process for analyzing proteins from cancer biopsy samples, and was excited to hear Dr. G. Larry Maxwell deem Pressure’ PCT instrument as an ‘essential requirement for our novel workflow in meeting our goals.’

Quick facts: Pressure BioSciences, Inc.

Price: 2.4 USD

OTCQB:PBIO
Market: OTCQB
Market Cap: $5.76 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Pressure BioSciences, Inc. named herein, including the promotion by the Company of Pressure BioSciences, Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Immotion plans fundraising following deal with Las Vegas resort

Immotion Group (LON:IMMO) has raised gross proceeds of £2.85mln from an 'oversubscribed' fundraising to accelerate its growth plans, and revealed it has inked a revenue-sharing deal with the MGM Mandalay Bay resort and casino in Las Vegas. CEO Martin Higginson tells Proactive London what the...

1 day, 15 hours ago

2 min read